EGM
MIST icon

Engineers Gate Manager’s Milestone Pharmaceuticals MIST Stock Holding History

Engineers Gate Manager’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,053
Closed -$119K – 2415
2025
Q4 		$119K Buy
+59,053
New +$127K ﹤0.01% 1893
2024
Q4 		– Sell
-11,074
Closed -$16.8K – 2446
2024
Q3 		$16.8K Buy
+11,074
New +$16.1K ﹤0.01% 2039
2024
Q1 		– Sell
-13,135
Closed -$21.9K – 2151
2023
Q4 		$21.9K Buy
+13,135
New +$35.7K ﹤0.01% 1902
2022
Q4 		– Sell
-11,800
Closed -$108K – 1891
2022
Q3 		$108K Buy
+11,800
New +$89.5K 0.01% 1442

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Engineers Gate Manager's MIST Position: Q1 2026 in Review

Engineers Gate Manager sold out of Milestone Pharmaceuticals (MIST) in Q1 2026, closing a stake of 59,053 shares — an estimated $119K sold.

Engineers Gate Manager first reported a position in MIST in Q3 2022 and held it in 4 quarters. The position peaked at $119K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Engineers Gate Manager reported no remaining Milestone Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 59,053 Milestone Pharmaceuticals shares in Q1 2026, an estimated $119K.
  • Engineers Gate Manager first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • Engineers Gate Manager's Milestone Pharmaceuticals position peaked at $119K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.